Ketoconazole Retains Activity in Advanced Prostate Cancer Patients with Progression Despite Flutamide Withdrawal

REFERENCES 

1. Smith DC , Bahnson RR , Trump DL . Secondary hormonal manipulation . In:  Vogelzang NJ ,  Scardino PT ,  Shipley WU ,  Coffey DS ,  Miles BJ editor. Comprehensive Textbook of Genitourinary Oncology . Baltimore: Williams & Wilkins; 1996;p. 885–890 chapt. 48A
2. Dawson NA . Treatment of progressive metastatic prostate cancer . Oncology . 1993;7:17
3. Scher HI , Kelly WK . Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer . J. Clin. Oncol. . 1993;11:1566
   • MEDLINE
4. Small EJ , Srinivas S . The antiandrogen withdrawal syndrome. Experience in a large cohort of unselected patients with advanced prostate cancer . Cancer . 1995;76:1428
   • MEDLINE
   • CrossRef
5. Figg WD, Sartor O, Cooper MR, Thibault A, Bergan RC, Dawson N, et al. Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer . Amer. J. Med. . 1995;98:412
6. Herrada J , Dieringer P , Logothetis CJ . Characterization of patients with androgen-independent prostatic carcinoma whose serum prostate specific antigen decreased following flutamide withdrawal . J. Urol. . 1996;155:620
   • Abstract
   • Full Text
   • Full-Text PDF (777 KB)
   • CrossRef
7. Scher HI , Steineck G , Kelly WK . Hormone-refractory (D3) prostate cancer: refining the concept . Urology . 1995;46:142
   • Abstract
   • Full-Text PDF (796 KB)
   • CrossRef
8. Trachtenberg J , Halpern N , Pont A . Ketoconazole: a novel and rapid treatment for advanced prostatic cancer . J. Urol. . 1983;130:152
   • MEDLINE
9. Trachtenberg J , Pont A . Ketoconazole therapy for advanced prostate cancer . Lancet . 1984;2:433
   • CrossRef
10. Tapazoglou E , Subramanian MG , Al-Sarraf M , Kresge C , Decker DA . High-dose ketoconazole therapy in patients with metastatic prostate cancer . Amer. J. Clin. Oncol. . 1986;9:369
11. Williams G, Kerle DJ, Ware H, Doble A, Dunlop H, Smith C, et al. Objective responses to ketoconazole therapy in patients with relapsed progressive prostatic cancer . Brit. J. Urol. . 1986;58:45
12. Gerber GS , Chodak GW . Prostate specific antigen for assessing response to ketoconazole and prednisone in patients with hormone refractory metastatic prostate cancer . J. Urol. . 1990;144:1177
    • MEDLINE
13. Trump DL , Havlin KH , Messing EM , Cummings KB , Lange PH , Jordan VC . High-dose ketoconazole in advanced hormone-refractory prostate cancer: endocrinologic and clinical effects . J. Clin. Oncol. . 1989;7:1093
    • MEDLINE
14. Muscato JJ , Ahmann TA , Johnson KM . Optimal dosing of ketoconazole (keto) and hydrocortisone (HC) leads to long responses in hormone refractory prostate cancer . Proc. Amer. Soc. Clin. Oncol. . 1994;13:229
15. Veldscholte J , Berrevoets CA , Brinkmann AO , Grootegoed JA , Mulder E . Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation . Biochem. . 1992;31:2393
16. Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer . New Engl. J. Med. . 1995;332:1393
17. Sartor O, Cooper M, Weinberger M, Headlee D, Thibault A, Tompkins A, et al. Surprising activity of flutamide withdrawal, when combined with aminoglutethimide, in treatment of “hormone-refractory” prostate cancer . J. Natl. Cancer Inst. . 1994;86:222
    • MEDLINE
    • CrossRef
18. Kelly WK , Scher HI , Mazumdar M , Vladmis V , Schwartz M , Fossa SD . Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer . J. Clin. Oncol. . 1993;11:607
    • MEDLINE
19. Scher HI, Curley T, Geller N, Engstrom C, Dershaw DD, Lin SY, et al. Trimetrexate in prostatic cancer: preliminary observations on the use of prostate-specific antigen and acid phosphatase as a marker in measurable hormone-refractory disease . J. Clin. Oncol. . 1990;8:1830
    • MEDLINE
20. Sridhara R , Eisenberger MA , Sinibaldi VJ , Reyno LM , Egorin MJ . Evaluation of prostate-specific antigen as a surrogate marker for response of hormone-refractory prostate cancer to suramin therapy . J. Clin. Oncol. . 1995;13:2944
    • MEDLINE